vs

Side-by-side financial comparison of First Northwest Bancorp (FNWB) and IRIDEX CORP (IRIX). Click either name above to swap in a different company.

First Northwest Bancorp is the larger business by last-quarter revenue ($18.4M vs $14.7M, roughly 1.2× IRIDEX CORP). On growth, First Northwest Bancorp posted the faster year-over-year revenue change (19.1% vs -69.7%). Over the past eight quarters, IRIDEX CORP's revenue compounded faster (11.9% CAGR vs 6.8%).

First Midwest Bancorp, Inc. was headquartered in Chicago, Illinois, just east of O'Hare Airport. The company's predecessor traces back to Joliet, Illinois. From there the company has grown to serve many Chicago suburbs including northwest Indiana, downstate Illinois, southeast Wisconsin and the Quad Cities area including Iowa. First Midwest Bank is one of the largest banking institutions in the United States

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

FNWB vs IRIX — Head-to-Head

Bigger by revenue
FNWB
FNWB
1.2× larger
FNWB
$18.4M
$14.7M
IRIX
Growing faster (revenue YoY)
FNWB
FNWB
+88.8% gap
FNWB
19.1%
-69.7%
IRIX
Faster 2-yr revenue CAGR
IRIX
IRIX
Annualised
IRIX
11.9%
6.8%
FNWB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FNWB
FNWB
IRIX
IRIX
Revenue
$18.4M
$14.7M
Net Profit
$382.0K
Gross Margin
37.2%
Operating Margin
6.2%
Net Margin
2.6%
Revenue YoY
19.1%
-69.7%
Net Profit YoY
113.6%
EPS (diluted)
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FNWB
FNWB
IRIX
IRIX
Q4 25
$18.4M
$14.7M
Q3 25
$16.6M
$12.5M
Q2 25
$16.4M
$13.6M
Q1 25
$17.6M
$11.9M
Q4 24
$15.4M
$12.7M
Q3 24
$15.8M
$11.6M
Q2 24
$21.6M
$12.6M
Q1 24
$16.1M
$11.8M
Net Profit
FNWB
FNWB
IRIX
IRIX
Q4 25
$382.0K
Q3 25
$802.0K
$-1.6M
Q2 25
$3.7M
$-994.0K
Q1 25
$-9.0M
$-1.7M
Q4 24
$-2.8M
$-834.0K
Q3 24
$-2.0M
$-1.9M
Q2 24
$-2.2M
$-2.7M
Q1 24
$396.0K
$-3.5M
Gross Margin
FNWB
FNWB
IRIX
IRIX
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
FNWB
FNWB
IRIX
IRIX
Q4 25
6.2%
Q3 25
-0.9%
-11.3%
Q2 25
24.2%
-6.9%
Q1 25
-57.7%
-1.7%
Q4 24
-17.3%
-3.9%
Q3 24
-20.1%
-16.1%
Q2 24
-12.8%
-20.9%
Q1 24
5.2%
-28.0%
Net Margin
FNWB
FNWB
IRIX
IRIX
Q4 25
2.6%
Q3 25
4.8%
-12.6%
Q2 25
22.4%
-7.3%
Q1 25
-51.3%
-14.2%
Q4 24
-19.9%
-6.6%
Q3 24
-12.5%
-16.7%
Q2 24
-10.3%
-21.2%
Q1 24
2.5%
-29.5%
EPS (diluted)
FNWB
FNWB
IRIX
IRIX
Q4 25
$0.04
Q3 25
$0.09
$-0.09
Q2 25
$0.42
$-0.06
Q1 25
$-1.03
$-0.10
Q4 24
$-0.31
$-0.05
Q3 24
$-0.23
$-0.12
Q2 24
$-0.25
$-0.16
Q1 24
$0.04
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FNWB
FNWB
IRIX
IRIX
Cash + ST InvestmentsLiquidity on hand
$6.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$157.3M
Total Assets
$2.1B
$29.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FNWB
FNWB
IRIX
IRIX
Q4 25
$6.0M
Q3 25
$5.6M
Q2 25
$6.8M
Q1 25
$7.2M
Q4 24
$2.4M
Q3 24
$3.9M
Q2 24
$4.1M
Q1 24
$5.4M
Total Debt
FNWB
FNWB
IRIX
IRIX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
FNWB
FNWB
IRIX
IRIX
Q4 25
$157.3M
Q3 25
$154.5M
$4.7M
Q2 25
$149.7M
$6.1M
Q1 25
$146.5M
$852.0K
Q4 24
$153.9M
$2.1M
Q3 24
$160.8M
$2.6M
Q2 24
$158.9M
$4.2M
Q1 24
$160.5M
$6.5M
Total Assets
FNWB
FNWB
IRIX
IRIX
Q4 25
$2.1B
$29.2M
Q3 25
$2.1B
$28.4M
Q2 25
$2.2B
$31.6M
Q1 25
$2.2B
$34.2M
Q4 24
$2.2B
$29.1M
Q3 24
$2.3B
$30.2M
Q2 24
$2.2B
$31.2M
Q1 24
$2.2B
$34.1M
Debt / Equity
FNWB
FNWB
IRIX
IRIX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FNWB
FNWB
IRIX
IRIX
Operating Cash FlowLast quarter
$-2.8M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
-7.22×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FNWB
FNWB
IRIX
IRIX
Q4 25
$-2.8M
Q3 25
$4.7M
$-1.2M
Q2 25
$4.0M
$-397.0K
Q1 25
$-21.7M
$-1.1M
Q4 24
$16.9M
$-1.2M
Q3 24
$1.2M
$-3.1M
Q2 24
$8.1M
$-1.3M
Q1 24
$-4.9M
$-1.6M
Free Cash Flow
FNWB
FNWB
IRIX
IRIX
Q4 25
Q3 25
$-1.2M
Q2 25
$-410.0K
Q1 25
$-1.2M
Q4 24
$-1.2M
Q3 24
$-3.1M
Q2 24
Q1 24
$-5.0M
$-1.7M
FCF Margin
FNWB
FNWB
IRIX
IRIX
Q4 25
Q3 25
-9.4%
Q2 25
-3.0%
Q1 25
-9.8%
Q4 24
-9.8%
Q3 24
-26.5%
Q2 24
Q1 24
-30.9%
-14.0%
Capex Intensity
FNWB
FNWB
IRIX
IRIX
Q4 25
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.7%
0.0%
Cash Conversion
FNWB
FNWB
IRIX
IRIX
Q4 25
-7.22×
Q3 25
5.89×
Q2 25
1.08×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-12.29×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons